Neuropsychiatric non-motor aspects of Parkinson's disease

被引:44
作者
Thanvi, BR
Munshi, SK
Vijaykumar, N
Lo, TCN
机构
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Integrated Med, Leicester LE5 4PW, Leics, England
[2] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Dept Integrated Med, Leicester, Leics, England
关键词
LEVODOPA-INDUCED PSYCHOSIS; DEPRESSION; HALLUCINATIONS; COMORBIDITY; SYMPTOMS; ANXIETY;
D O I
10.1136/pmj.79.936.561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parkinson's disease is often recognised as a motor disease characterised by rest tremor, rigidity, bradykinesia, and postural disturbances. However, there are several non-motor aspects of the disease that are of at least equal importance in the management of patients with Parkinson's disease. They include depression, cognitive impairment, anxiety, and psychosis among others. It is important to recognise them, as they are common and they contribute significantly to patients' morbidity, quality of life, and institutionalisation to long term care homes. In addition to the disease duration and severity, other factors including drugs may contribute to their occurrence. Pathogenesis of these aspects is not fully understood, though there has been a significant increase in the knowledge in recent years. Management of these aspects involves a multidisciplinary approach..
引用
收藏
页码:561 / 565
页数:5
相关论文
共 32 条
[21]   MOOD CHANGES AND ON-OFF PHENOMENA IN PARKINSONS-DISEASE [J].
MENZA, MA ;
SAGE, J ;
MARSHALL, E ;
CODY, R ;
DUVOISIN, R .
MOVEMENT DISORDERS, 1990, 5 (02) :148-151
[22]  
PARKINSON J, 1992, ESSAY SHAKING PALSY
[23]   Visual hallucinations associated with Parkinson disease [J].
SanchezRamos, JR ;
Ortoll, R ;
Paulson, GW .
ARCHIVES OF NEUROLOGY, 1996, 53 (12) :1265-1268
[24]  
SHAJAHAN P, 1998, PROG NEUROL PSYCHIAT, V12, P55
[25]   Comorbidity of the nonmotor symptoms of Parkinson's disease [J].
Shulman, LM ;
Taback, RL ;
Bean, J ;
Weiner, WJ .
MOVEMENT DISORDERS, 2001, 16 (03) :507-510
[26]   Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease [J].
Slaughter, JR ;
Slaughter, KA ;
Nichols, D ;
Holmes, SE ;
Martens, RP .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 13 (02) :187-196
[27]   Zotepine in levodopa-induced psychosis [J].
Spieker, S ;
Stetter, F ;
Klockgether, T .
MOVEMENT DISORDERS, 1995, 10 (06) :795-797
[28]   DEPRESSION IN PARKINSONS-DISEASE [J].
STARKSTEIN, SE ;
PREZIOSI, TJ ;
BOLDUC, PL ;
ROBINSON, RG .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1990, 178 (01) :27-31
[29]   Parkinson's disease and anxiety [J].
Walsh, K ;
Bennett, G .
POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (904) :89-93
[30]   Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease [J].
Wolters, EC ;
Jansen, ENH ;
TuynmanQua, HG ;
Bergmans, PLM .
NEUROLOGY, 1996, 47 (04) :1085-1087